Standout Papers

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted T... 2018 2026 2020 2023 331
  1. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update (2018)
    Gregory P. Kalemkerian, Navneet Narula et al. Journal of Clinical Oncology

Immediate Impact

64 standout
Sub-graph 1 of 24

Citing Papers

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Lung cancer statistics, 2023
2024 Standout
2 intermediate papers

Works of Madelyn Lew being referenced

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update
2018 Standout

Author Peers

Author Last Decade Papers Cites
Madelyn Lew 156 394 95 224 208 45 712
Dean Ruether 203 238 45 257 92 39 690
Mauro Saieg 224 321 128 237 173 60 751
Tian Tian 80 228 71 264 94 67 836
Sarah Rudman 249 307 66 243 140 38 762
R. Bracci 179 338 25 333 170 41 746
Sung Soo Chang 178 498 47 166 60 37 795
Rangesh Kunnavakkam 203 407 33 242 155 29 775
L. Iglesias 93 197 103 389 142 36 742
G. Bonardel 249 160 161 154 114 54 685
A. Robinson 122 234 21 390 326 34 747

All Works

Loading papers...

Rankless by CCL
2026